CapitolRadar tracks every publicly disclosed ATR trade by US congress members and corporate insiders: 13 disclosed trades (8 buys, 5 sells) by 3 tracked traders, from 2019-07-12 to 2026-06-18. Updated daily from official filings.
Want a ping when Congress buys ATR? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
AptarGroup, Inc. (ATR) — Healthcare · Medical - Instruments & Supplies, market cap about $7.7B.
CapitolRadar analysis
13 tracked ATR trades, with buys leading 8 to 5
13 disclosed trades in AptarGroup, Inc. (ATR) are tracked from July 12, 2019 through June 18, 2026. The activity comprises 8 buys and 5 sells by 3 distinct traders. That gives purchases a modest numerical lead, but the sample is small and spread across nearly seven years. ATR is classified in Healthcare and the Medical - Instruments & Supplies industry.
The quarterly record is intermittent rather than continuous. Three trades in 2019 Q3 were all sells. Later activity included one buy in 2022 Q1, one buy in 2022 Q3, two buys in 2023 Q4, and one sell in 2024 Q3. The record then shows two buys in 2025 Q3, one buy in 2025 Q4, and two trades in 2026 Q2, of which one was a buy.
7 of 8 purchases came from Michael McCaul
Michael McCaul accounts for 7 of the 8 tracked ATR buys, with his latest purchase dated June 12, 2026. Ro Khanna accounts for the remaining buy, dated February 14, 2022. Although 3 distinct traders appear in the full trade history, the supplied data identifies only these two buyers and does not attribute the 5 sales by name.
6 overlapping tickers appear across both buyers
Both identified ATR buyers also purchased BAX, DELL, SWK, SPGI, INTU and BSX. Each overlap involves 2 buyers, but this is only a two-person buyer sample, so the shared names should not be treated as evidence of a broad trading pattern.
Congressional disclosures can be filed up to 45 days after a transaction, creating a reporting lag. Transaction amounts, when reported as ranges, are estimates rather than exact values; no amount ranges are provided here. The limited number of trades and traders also constrains comparisons across quarters and individuals.
Analysis written from the tracked record on 2026-09-06; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q2 | 2 | 1 | 1 |
| 2025 Q4 | 1 | 1 | 0 |
| 2025 Q3 | 2 | 2 | 0 |
| 2024 Q3 | 1 | 0 | 1 |
| 2023 Q4 | 2 | 2 | 0 |
| 2022 Q3 | 1 | 1 | 0 |
| 2022 Q1 | 1 | 1 | 0 |
| 2019 Q3 | 3 | 0 | 3 |
Who is buying ATR?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Michael McCaul | 7 | 2026-06-12 | — |
| Ro Khanna | 1 | 2022-02-14 | — |
Disclosed trades in ATR
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-06-18 | Michael McCaul | sell | $1,001 - $15,000 | — |
| 2026-06-12 | Michael McCaul | buy | $15,001 - $50,000 | — |
| 2025-11-19 | Michael McCaul | buy | $15,001 - $50,000 | — |
| 2025-09-22 | Michael McCaul | buy | $15,001 - $50,000 | — |
| 2025-09-11 | Michael McCaul | buy | $1,001 - $15,000 | — |
| 2024-08-26 | Michael McCaul | sell | $1,001 - $15,000 | — |
| 2023-11-01 | Michael McCaul | buy | $15,001 - $50,000 | — |
| 2023-11-01 | Michael McCaul | buy | $1,001 - $15,000 | — |
| 2022-08-08 | Michael McCaul | buy | $50,001 - $100,000 | — |
| 2022-02-14 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2019-09-13 | Susie Lee | sell | $1,001 - $15,000 | — |
| 2019-09-11 | Susie Lee | sell | $1,001 - $15,000 | — |
| 2019-07-12 | Susie Lee | sell | $1,001 - $15,000 | — |
These buyers also bought
Other stocks the tracked buyers of ATR disclosed buying in the last six months: WDAY (2) · AJG (2) · DHR (2) · TSM (2) · TER (2) · P (2).
About AptarGroup, Inc.
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler va…
Frequently asked questions
Which politicians bought ATR most?
Michael McCaul leads with 7 disclosed buys, followed by Ro Khanna.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.